News | Radiation Therapy | May 20, 2016

Keynote speakers to include former HHS Secretary Sebelius, Delta Airlines safety executive and Massachusetts General Hospital physicians group CEO

May 20, 2016 — Registration opened this week for the American Society for Radiation Oncology’s (ASTRO) 58th Annual Meeting, Sept. 25-28 at the Boston Convention and Exhibition Center.

This year’s meeting will feature a record number of abstracts, scientific and educational presentations on radiation oncology clinical trials, and research and keynote addresses from former U.S. Secretary of Health and Human Services Kathleen Sebelius, the current chair and CEO of the Massachusetts General Physicians Organization, and a top safety executive from Delta Air Lines.

The meeting is expected to attract more than 11,000 attendees from across the globe, including oncologists from all disciplines and members of the entire radiation oncology team.

Led by ASTRO President David C. Beyer, M.D., FASTRO, the 2016 meeting is organized around the theme, “Enhancing Value, Improving Outcomes,” echoing growing calls from policy makers, physicians and patients for value-based healthcare. “The goal of ASTRO’s 2016 Annual Meeting is to highlight the latest scientific and technological advances while emphasizing the importance of radiation oncology in providing value to cancer patients through cure and palliation,” said Beyer.

Three keynote addresses will examine various aspects of value in healthcare, such as safety, quality and access. Keynote speakers include:

  • Kathleen Sebelius, former U.S. Secretary of Health and Human Services;
  • Thomas James Lynch Jr., M.D., chair and chief executive officer, Massachusetts General Physicians Organization; and
  • Jason Ragogna, general manager, SMS and safety alliances, corporate safety, security and compliance, Delta Air Lines Inc.

The Presidential Symposium, “Prostate Cancer: Defining Value and Delivering It,” will feature Louis Potters, M.D., FASTRO, and Jeff M. Michalski, M.D., FASTRO, to highlight recent practice-changing landmark studies and current developments in the value-based care for prostate cancer.

Concurrent with the scientific and educational program, more than 200 exhibitors will demonstrate the latest cutting-edge technology and medical device innovations for radiation oncology.

For more information: www.astro.org


Related Content

News | Women's Health

Nov. 3, 2025 — —A new radioimmunotherapy approach has the potential to cure human epidermal growth factor receptor 2 ...

Time November 04, 2025
arrow
Feature | Kyle Hardner

Radiotherapy contributes to about 40% of all cancer cures but still lags behind systemic therapy in funding and ...

Time October 21, 2025
arrow
News | Radiation Oncology

Sept. 02, 2025 — Alpha Tau Medical Ltd., the developer of the alpha-radiation cancer therapy Alpha DaRT has announced ...

Time September 05, 2025
arrow
News | Radiation Oncology

May 2, 2025 — GE HealthCare has announced an intended expansion of its radiation oncology portfolio as well as the ...

Time May 03, 2025
arrow
News | Radiology Education

April 21, 2025 — On June 20, the American Society of Radiologic Technologists (ASRT) will award Life Member status to ...

Time April 21, 2025
arrow
News | Radiology Business

April 16, 2025 — According to a new report, the U.S. Radiotherapy Market is projected to reach $2.49 billion by 2030 ...

Time April 17, 2025
arrow
News | ASTRO

March 14, 2025 — Another pivotal milestone in the nation’s fight against cancer recently took place with the ...

Time March 17, 2025
arrow
News | Computed Tomography (CT)

Royal Philips recently received 510(k) clearance from the US Food and Drug Administration (FDA) for its detector-based ...

Time November 13, 2024
arrow
News

Aug. 5, 2024 — Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding ...

Time August 09, 2024
arrow
News | PET-CT

July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...

Time July 31, 2024
arrow
Subscribe Now